Acanthamoeba polyphaga strain age and method of cyst production influence the observed efficacy of therapeutic agents and contact lens disinfectants

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 10, 2003, Pages 3080-3084

  Hughes, Reanne ^a   Heaselgrave, Wayne ^a   Kilvington, Simon ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPROTOZOAL AGENT; BAQUACIL; BIGUANIDE DERIVATIVE; CHLORHEXIDINE; CHLORHEXIDINE GLUCONATE; CONTACT LENS SOLUTION; DISINFECTANT AGENT; DRUG DERIVATIVE; HYDROGEN PEROXIDE; MAGNESIUM CHLORIDE; MYRISTAMIDOPROPYL DIMETHYLAMINE; POLY(HEXAMETHYLENEBIGUANIDE); PROPYLAMINE; UNCLASSIFIED DRUG;

ACANTHAMOEBA; ACANTHAMOEBA POLYPHAGA; AGE; ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; BACTERIAL COUNT; CELL KILLING; CELL VIABILITY; CONTACT LENS; CONTROLLED STUDY; CRYOPRESERVATION; DISINFECTION; DRUG EFFECT; DRUG EFFICACY; DRUG SCREENING; DRUG SENSITIVITY; ESCHERICHIA COLI; GERMFREE ANIMAL; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; METHODOLOGY; NONHUMAN; PARASITE CULTIVATION; PARASITOLOGY; PRIORITY JOURNAL; STANDARDIZATION; TROPHOZOITE;

ACANTHAMOEBA; AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; ANTIPROTOZOAL AGENTS; BIGUANIDES; CHLORHEXIDINE; COLONY COUNT, MICROBIAL; CONTACT LENS SOLUTIONS; CONTACT LENSES; DISINFECTION; HYDROGEN PEROXIDE; PROPYLAMINES;

EID: 0141925611     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.10.3080-3084.2003     Document Type: Article

References (36)

1. Anger, C., D. Rupp, M. Pomrenke, and S. Kapadia. 1991. A quantitative bacterial plaque assay for the enumeration of viable Acanthamoeba cells. Rev. Infect. Dis. 13(Suppl. 5):S396.
2. Borazjani, R. N., L. L. May, J. A. Noble, S. V. Avery, and D. G. Ahearn. 2000. Flow cytometry for determination of the efficacy of contact lens disinfecting solutions against Acanthamoeba spp. Appl. Environ. Microbiol. 66:1057-1061.
3. Brandt, F. H., D. A. Ware, and G. S. Visvesvara. 1989. Viability of Acanthamoeba cysts in ophthalmic solutions. Appl. Environ. Microbiol. 55:1144-1146.
4. Buck, S. L., and R. A. Rosenthal. 1996. A quantitative method to evaluate neutralizer toxicity against Acanthamoeba castellanii. Appl. Environ. Microbiol. 62:3521-3526.
5. Buck, S. L., R. A. Rosenthal, and R. L. Abshire. 1998. Amoebicidal activity of a preserved contact lens multipurpose disinfecting solution compared with a disinfection/neutralisation peroxide system. Contact Lens Anterior Eye 21:81-84.
6. Buck, S. L., R. A. Rosenthal, and B. A. Schlech. 2000. Methods used to evaluate the effectiveness of contact lens care solutions and other compounds against Acanthamoeba: a review of the literature. CLAO J. 26:72-84.
7. Byers, T. J., B. G. Kim, L. E. King, and E. R. Hugo. 1991. Molecular aspects of the cell cycle and encystment of Acanthamoeba. Rev. Infect. Dis. 13 (Suppl. 5):S373-S384.
8. Hiti, K., J. Walochnik, E. M. Haller-Schober, C. Faschinger, and H. Aspock. 2002. Viability of Acanthamoeba after exposure to a multipurpose disinfecting contact lens solution and two hydrogen peroxide systems. Br. J. Ophthalmol. 86:144-146.
9. Hughes, R., and S. Kilvington. 2001. Comparison of hydrogen peroxide contact lens disinfection systems and solutions against Acanthamoeba polyphaga. Antimicrob. Agents Chemother. 45:2038-2043.
10. Hugo, E. R., W. R. McLaughlin, K. H. Oh, and O. H. Tuovinen. 1991. Quantitative enumeration of Acanthamoeba for evaluation of cyst inactivation in contact lens care solutions. Investig. Ophthalmol. Vis. Sci. 32:655-657.
11. International Organization for Standardization. 2000. Ophthalmic optics-contact lens care products-microbiological requirements and test methods for products and regimens for hygienic management of contact lenses. ISO/CD 14729. International Organization for Standardization, Geneva, Switzerland.
12. Khunkitti, W., D. Lloyd, J. R. Furr, and A. D. Russell. 1998. Acanthamoeba castellanii: growth, encystment, excystment and biocide susceptibility. J. Infect. 36:43-48.
13. Kilvington, S., R. Hughes, J. Byas, and J. Dart. 2002. Activities of therapeutic agents and myristamidopropyl dimethylamine against Acanthamoeba isolates. Antimicrob. Agents Chemother. 46:2007-2009.
14. Kilvington, S., and C. Anger. 2001. A comparison of cyst age and assay method of the efficacy of contact lens disinfectants against Acanthamoeba. Br. J. Ophthalmol. 85:336-340.
15. Kilvington, S., D. F. Larkin, D. G. White, and J. R. Beeching. 1990. Laboratory investigation of Acanthamoeba keratitis. J. Clin. Microbiol. 28:2722-2725.
16. Kilvington, S., and D. G. White. 1991. A simple method for the cryopreservation of free-living amoebae belonging to the genera Naegleria and Acanthamoeba. Eur. J. Protistol. 27:115-118.
17. Lever, A., and R. N. Borazjani. 2001. Comparative antimicrobial efficacy of multi-purpose hydrogel lens care solutions. Contact Lens Anterior Eye 24: 94-99.
18. Lloyd, D., N. A. Turner, W. Khunkitti, A. C. Hann, J. R. Furr, and A. D. Russell. 2001. Encystation in Acanthamoeba castellanii: development of biocide resistance. J. Eukaryot. Microbiol. 48:11-16.
19. Marciano-Cabral, F., R. Puffenbarger, and G. A. Cabral. 2000. The increasing importance of Acanthamoeba infections. J. Eukaryot. Microbiol. 47:29-36.
20. Mazur, T., E. Hadas, and I. Iwanicka. 1995. The duration of the cyst stage and the viability and virulence of Acanthamoeba isolates. Trop. Med. Parasitol. 46:106-108.
21. Mazur, T., and E. Hadas. 1994. The effect of the passages of Acanthamoeba strains through mice tissues on their virulence and its biochemical markers. Parasitol. Res. 80:431-434.
22. Neff, R. J., S. A. Ray, W. F. Benton, and M. Wilborn. 1964. Induction of synchronous encystment (differentiation) in Acanthamoeba sp. Methods Cell Physiol. 1:55-83.
23. Niszl, I. A., and M. B. Markus. 1998. Anti-Acanthamoeba activity of contact lens solutions. Br. J. Ophthalmol. 82:1033-1038.
24. Noble, J. A., D. G. Ahearn, S. V. Avery, and S. A. Crow, Jr. 2002. Phagocytosis affects biguanide sensitivity of Acanthamoeba spp. Antimicrob. Agents Chemother. 46:2069-2076.
25. Page, F. C. 1988. A new key to freshwater and soil gymnamoebae. Freshwater Biological Association, Ambleside, England.
26. Radford, C. F., D. C. Minassian, and J. K. Dart. 2002. Acanthamoeba keratitis in England and Wales: incidence, outcome, and risk factors. Br. J. Ophthalmol. 86:536-542.
27. Radford, C. F., O. J. Lehmann, and J. K. Dart for the National Acanthamoeba Keratitis Study Group. 1998. Acanthamoeba keratitis: multicentre survey in England 1992-6. Br. J. Ophthalmol. 82:1387-1392.
28. Radford, C. F., A. S. Bacon, J. K. G. Dart, and D. C. Minassian. 1995. Risk factors for acanthamoeba keratitis in contact lens users: a case control study. Br. Med. J. 10:1567-1570.
29. Reed, L. J., and H. Muench. 1938. A simple method for estimating fifty percent endpoints. Am. J. Hyg. 27:493-497.
30. Rosenthal, R. A., J. M. Stein, C. L. McAnally, and B. A. Schlech. 1995. A comparative study of the microbiologic effectiveness of chemical disinfectants and peroxide-neutralizer systems. CLAO J. 21:99-110.
31. Silvany, R. E., J. M. Dougherty, and J. P. McCulley. 1991. Effects of contact lens preservatives on Acanthamoeba. Ophthalmology 98:854-857.
32. Singh, B. N. 1975. Pathogenic and non-pathogenic amoeba. Macmillan, London, United Kingdom.
33. Stehr-Green, J. K., T. M. Bailey, and G. S. Visvesvara. 1989. The epidemiology of Acanthamoeba keratitis in the United States. Am. J. Ophthalmol. 107:331-336.
34. Turner, N. A., A. D. Russell, J. R. Furr, and D. Lloyd. 2000. Emergence of resistance to biocides during differentiation of Acanthamoeba castellanii. J. Antimicrob. Chemother. 46:27-34.
35. Van Duzee, B., and B. Schlech. 1999. The activity of a multi-purpose solution against Acanthamoeba. Optician 217:34-35.
36. Visvesvara, G. S. 1991. Classification of Acanthamoeba. Rev. Infect. Dis. 13: S369-S372.